Zobrazeno 1 - 10
of 181
pro vyhledávání: '"MESH: Pseudomonas aeruginosa"'
Autor:
Adrien, Bouglé, Sophie, Tuffet, Laura, Federici, Marc, Leone, Antoine, Monsel, Thomas, Dessalle, Julien, Amour, Claire, Dahyot-Fizelier, François, Barbier, Charles-Edouard, Luyt, Olivier, Langeron, Bernard, Cholley, Julien, Pottecher, Tarik, Hissem, Jean-Yves, Lefrant, Benoit, Veber, Matthieu, Legrand, Alexandre, Demoule, Pierre, Kalfon, Jean-Michel, Constantin, Alexandra, Rousseau, Tabassome, Simon, Arnaud, Foucrier, Nora, Soussi
Publikováno v:
Intensive Care Medicine
Intensive Care Medicine, 2022, 48 (7), pp.841-849. ⟨10.1007/s00134-022-06690-5⟩
Intensive Care Medicine, 2022, 48 (7), pp.841-849. ⟨10.1007/s00134-022-06690-5⟩
International audience; Purpose: Duration of antibiotic therapy for ventilator-associated pneumonia (VAP) due to non-fermenting Gram-negative bacilli (NF-GNB), including Pseudomonas aeruginosa (PA) remains uncertain. We aimed to assess the non-inferi
Autor:
Agnès B. Jousset, Sandrine Bernabeu, Cécile Emeraud, Rémy A. Bonnin, Alexandra Lomont, Jean Ralph Zahar, Audrey Merens, Christophe Isnard, Nathalie Soismier, Eric Farfour, Vincent Fihman, Nicolas Yin, Olivier Barraud, Hervé Jacquier, Anne-Gaëlle Ranc, Frédéric Laurent, Stéphane Corvec, Louise Ruffier d'Epenoux, Emmanuelle Bille, Nicolas Degand, Chloé Plouzeau, Thomas Guillard, Vincent Cattoir, Asaf Mizrahi, Antoine Grillon, Frédéric Janvier, Cécile Le Brun, Marlène Amara, Mathilda Bastide, Alban Lemonnier, Laurent Dortet
Publikováno v:
Journal of Global Antimicrobial Resistance
Journal of Global Antimicrobial Resistance, 2023, 32, pp.78-84. ⟨10.1016/j.jgar.2023.01.003⟩
Journal of Global Antimicrobial Resistance, 2023, 32, pp.78-84. ⟨10.1016/j.jgar.2023.01.003⟩
International audience; Objectives: Ceftolozane-tazobactam (C/T) proved its efficacy for the treatment of infections caused by non-carbapenemase producing Pseudomonas aeruginosa and Enterobacterales. Here, we aimed to provide susceptibility data on l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecd126d3d9f893524ff4e564b1b4de70
https://www.hal.inserm.fr/inserm-03962400/document
https://www.hal.inserm.fr/inserm-03962400/document
Autor:
Manon Janet-Maitre, Stéphane Pont, Frerich M. Masson, Serena Sleiman, Julian Trouillon, Mylène Robert-Genthon, Benoît Gallet, Chantal Dumestre-Perard, Sylvie Elsen, Christine Moriscot, Bart W. Bardoel, Suzan H. M. Rooijakkers, François Cretin, Ina Attrée
Publikováno v:
Plos Pathogens
PLoS Pathogens
PLoS Pathogens, 2023, 1386 (1), pp.325-345. ⟨10.1371/journal.ppat.1011023⟩
PLoS Pathogens, 2023, 19 (1), pp.e1011023. ⟨10.1371/journal.ppat.1011023⟩
PLoS Pathogens
PLoS Pathogens, 2023, 1386 (1), pp.325-345. ⟨10.1371/journal.ppat.1011023⟩
PLoS Pathogens, 2023, 19 (1), pp.e1011023. ⟨10.1371/journal.ppat.1011023⟩
Pseudomonas aeruginosa, an opportunistic Gram-negative pathogen, is a leading cause of bacteremia with a high mortality rate. We recently reported that P. aeruginosa forms a persister-like sub-population of evaders in human plasma. Here, using a gain
Publikováno v:
Pseudomonas aeruginosa
Pseudomonas aeruginosa, 1386, Springer International Publishing, pp.325-345, 2022, Advances in Experimental Medicine and Biology, ⟨10.1007/978-3-031-08491-1_12⟩
Advances in Experimental Medicine and Biology ISBN: 9783031084904
Pseudomonas aeruginosa, 1386, Springer International Publishing, pp.325-345, 2022, Advances in Experimental Medicine and Biology, ⟨10.1007/978-3-031-08491-1_12⟩
Advances in Experimental Medicine and Biology ISBN: 9783031084904
International audience; Bloodstream infections (BSI) with Pseudomonas aeruginosa account for 8.5% of all BSIs, their mortality rate, at about 40%, is the highest among causative agents. For this reason and due to its intrinsic and acquired resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95b6583a981fbbc0175d09718b8bd347
https://hal.science/hal-03917582
https://hal.science/hal-03917582
Autor:
Paolo Visca, Gabriele Sass, Karl V. Clemons, Shajia R Ansari, John C. Penner, Eric Déziel, David A. Stevens, Hasan Nazik, Hemi Shah, Hubertus Haas, Anna-Maria Dietl, Marie-Christine Groleau
Publikováno v:
Medical Mycology
Medical Mycology, Oxford University Press, 2019, 57 (Supplement_2), pp.S228-S232. ⟨10.1093/mmy/myy087⟩
Medical Mycology, Oxford University Press, 2019, 57 (Supplement_2), pp.S228-S232. ⟨10.1093/mmy/myy087⟩
International audience; In airways of immunocompromised patients and individuals with cystic fibrosis, Pseudomonas aeruginosa and Aspergillus fumigatus are the most common opportunistic bacterial and fungal pathogens. Both pathogens form biofilms and
Autor:
Moly Ba, Victoria Schmidt, Sophie de Bentzmann, Gaël Chambonnier, Corinne Sebban-Kreuzer, Christophe Bordi, Gauthier Dangla-Pélissier, Caroline Giraud, Nicolas Roux
Publikováno v:
Nucleic Acids Research
Nucleic Acids Research, 2021, 49 (19), pp.10956-10974. ⟨10.1093/nar/gkab827⟩
Nucleic Acids Research, 2021, 49 (19), pp.10956-10974. ⟨10.1093/nar/gkab827⟩
Pseudomonas aeruginosa is a major cause of nosocomial infections, particularly in immunocompromised patients or in individuals with cystic fibrosis. Genome sequences reveal that most P. aeruginosa strains contain a significant number of accessory gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67bf8d73a0b3a9913cc7c579bbab4728
https://hal-amu.archives-ouvertes.fr/hal-03557636
https://hal-amu.archives-ouvertes.fr/hal-03557636
Autor:
Carlos Contreras-Martel, Leandro F. Estrozi, Daniel M. Trindade, Mayara M. Miyachiro, Fernanda Rodrigues-Costa, Ina Attrée, Guy Schoehn, Caíque C. Malospirito, Alexandre Martins, Viviana Job, Andréa Dessen, Lionel Imbert, Manon Janet-Maitre
Publikováno v:
Nature Communications
Nature Communications, Nature Publishing Group, 2021, 12 (1), ⟨10.1038/s41467-021-22957-9⟩
Nature Communications, Nature Publishing Group, 2021, 12 (1), pp.2987. ⟨10.1038/s41467-021-22957-9⟩
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Nature Communications, 2021, 12 (1), pp.2987. ⟨10.1038/s41467-021-22957-9⟩
Nature Communications, Nature Publishing Group, 2021, 12 (1), ⟨10.1038/s41467-021-22957-9⟩
Nature Communications, Nature Publishing Group, 2021, 12 (1), pp.2987. ⟨10.1038/s41467-021-22957-9⟩
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Nature Communications, 2021, 12 (1), pp.2987. ⟨10.1038/s41467-021-22957-9⟩
The elongasome, or Rod system, is a protein complex that controls cell wall formation in rod-shaped bacteria. MreC is a membrane-associated elongasome component that co-localizes with the cytoskeletal element MreB and regulates the activity of cell w
Autor:
Manon Lounes, Salim Aberkane, Olivier Barraud, Radia Dali-Yahia, Sylvain Godreuil, Helen Jean Pierre, Abdelaziz Touati, Karima Zenati, Leila Yazi, Fatma Zohra Zaidi
Publikováno v:
Microbial Drug Resistance
Microbial Drug Resistance, Mary Ann Liebert, 2020, 26 (12), pp.1437-1441. ⟨10.1089/mdr.2019.0225⟩
Microbial Drug Resistance, Mary Ann Liebert, 2020, 26 (12), pp.1437-1441. ⟨10.1089/mdr.2019.0225⟩
International audience; Objectives: Pseudomonas aeruginosa occupies a central position in nosocomial infections and remains a significant cause of morbidity and mortality. The aim of this study was to characterize carbapenem resistance mechanisms in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42b19738b194c408452375fee7a6dbcb
https://hal.umontpellier.fr/hal-03384635
https://hal.umontpellier.fr/hal-03384635
Autor:
Laurent Debarbieux, Mathieu De Jode
Publikováno v:
médecine/sciences
médecine/sciences, EDP Sciences, 2019, 35 (11), pp.828-830. ⟨10.1051/medsci/2019161⟩
médecine/sciences, 2019, 35 (11), pp.828-830. ⟨10.1051/medsci/2019161⟩
médecine/sciences, EDP Sciences, 2019, 35 (11), pp.828-830. ⟨10.1051/medsci/2019161⟩
médecine/sciences, 2019, 35 (11), pp.828-830. ⟨10.1051/medsci/2019161⟩
International audience
Autor:
Béatrice Py, Joel Selkrig, Stephan Göttig, Ana Rita Brochado, Sunniva Foerster, Mikhail M. Savitski, Frédéric Barras, Anja Telzerow, Emily Huth, Athanasios Typas, Benjamin Ezraty, Stefan Bassler, Manuel Banzhaf, Jacob Bobonis, André Mateus, Matylda Zietek, Peer Bork, Jordi Zamarreño Beas, Natalie Ng
Publikováno v:
Nature
Nature, 2018, 559 (7713), pp.259-263. ⟨10.1038/s41586-018-0278-9⟩
Nature, Nature Publishing Group, 2018, 559 (7713), pp.259-263. ⟨10.1038/s41586-018-0278-9⟩
Nature, 2018, 559 (7713), pp.259-263. ⟨10.1038/s41586-018-0278-9⟩
Nature, Nature Publishing Group, 2018, 559 (7713), pp.259-263. ⟨10.1038/s41586-018-0278-9⟩
The spread of antimicrobial resistance has become a serious public health concern, making once-treatable diseases deadly again and undermining the achievements of modern medicine. Drug combinations can help to fight multi-drug-resistant bacterial inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d89c020eb71ab7d9c4f192b6ca53848
https://hal-amu.archives-ouvertes.fr/hal-01915461
https://hal-amu.archives-ouvertes.fr/hal-01915461